Banner specializes in controlling absorption and enhancing bioavailability of both insoluble and lipid-soluble compounds. Softgels provide an ideal delivery vehicle for these compounds, which make up a significant portion of the new actives coming out of discovery.

Through its commitment to innovation and meeting the needs of the marketplace, Banner has been able to create new softgel variants offering clear advantages over other dosage forms. With that, Banner distinguishes itself as a leading innovator in patented dosage form technology. The following dosage forms have been developed at Banner:

Patent applications have been filed for our drug delivery systems.